97 related articles for article (PubMed ID: 23239555)
21. Inhibitors of FabI, an enzyme drug target in the bacterial fatty acid biosynthesis pathway.
Lu H; Tonge PJ
Acc Chem Res; 2008 Jan; 41(1):11-20. PubMed ID: 18193820
[TBL] [Abstract][Full Text] [Related]
22. Ras inhibition via direct Ras binding--is there a path forward?
Wang W; Fang G; Rudolph J
Bioorg Med Chem Lett; 2012 Sep; 22(18):5766-76. PubMed ID: 22902659
[TBL] [Abstract][Full Text] [Related]
23. The antiproliferative agent didemnin B uncompetitively inhibits palmitoyl protein thioesterase.
Meng L; Sin N; Crews CM
Biochemistry; 1998 Jul; 37(29):10488-92. PubMed ID: 9671519
[TBL] [Abstract][Full Text] [Related]
24. Bivalent transition-state analogue inhibitors of human glyoxalase I.
Zheng ZB; Creighton DJ
Org Lett; 2003 Dec; 5(25):4855-8. PubMed ID: 14653691
[TBL] [Abstract][Full Text] [Related]
25. Discovery of Potent, Efficient, and Selective Inhibitors of Phosphoinositide 3-Kinase δ through a Deconstruction and Regrowth Approach.
Barton N; Convery M; Cooper AWJ; Down K; Hamblin JN; Inglis G; Peace S; Rowedder J; Rowland P; Taylor JA; Wellaway N
J Med Chem; 2018 Dec; 61(24):11061-11073. PubMed ID: 30532965
[TBL] [Abstract][Full Text] [Related]
26. The design and identification of brain penetrant inhibitors of phosphoinositide 3-kinase α.
Heffron TP; Salphati L; Alicke B; Cheong J; Dotson J; Edgar K; Goldsmith R; Gould SE; Lee LB; Lesnick JD; Lewis C; Ndubaku C; Nonomiya J; Olivero AG; Pang J; Plise EG; Sideris S; Trapp S; Wallin J; Wang L; Zhang X
J Med Chem; 2012 Sep; 55(18):8007-20. PubMed ID: 22946614
[TBL] [Abstract][Full Text] [Related]
27. Endothelial Palmitoylation Cycling Coordinates Vessel Remodeling in Peripheral Artery Disease.
Wei X; Adak S; Zayed M; Yin L; Feng C; Speck SL; Kathayat RS; Zhang Q; Dickinson BC; Semenkovich CF
Circ Res; 2020 Jul; 127(2):249-265. PubMed ID: 32233916
[TBL] [Abstract][Full Text] [Related]
28. Identifying the Potential Substrates of the Depalmitoylation Enzyme Acyl-protein Thioesterase 1.
Liu H; Yan P; Ren J; Wu C; Yuan W; Rao M; Zhang Z; Kong E
Curr Mol Med; 2019; 19(5):364-375. PubMed ID: 30914023
[TBL] [Abstract][Full Text] [Related]
29. Depalmitoylation and cell physiology: APT1 as a mediator of metabolic signals.
Speck SL; Wei X; Semenkovich CF
Am J Physiol Cell Physiol; 2024 Apr; 326(4):C1034-C1041. PubMed ID: 38344800
[TBL] [Abstract][Full Text] [Related]
30. Enzymatic depalmitoylation of viral glycoproteins with acyl-protein thioesterase 1 in vitro.
Veit M; Schmidt MF
Virology; 2001 Sep; 288(1):89-95. PubMed ID: 11543661
[TBL] [Abstract][Full Text] [Related]
31. Protein localization: Can too much lipid glue stop Ras?
Cox AD
Nat Chem Biol; 2010 Jul; 6(7):483-5. PubMed ID: 20559313
[No Abstract] [Full Text] [Related]
32. Therapeutic potential of boron-containing compounds.
Baker SJ; Ding CZ; Akama T; Zhang YK; Hernandez V; Xia Y
Future Med Chem; 2009 Oct; 1(7):1275-88. PubMed ID: 21426103
[TBL] [Abstract][Full Text] [Related]
33. Discovery and structure-activity relationships of novel piperidine inhibitors of farnesyltransferase.
Nara S; Tanaka R; Eishima J; Hara M; Takahashi Y; Otaki S; Foglesong RJ; Hughes PF; Turkington S; Kanda Y
J Med Chem; 2003 Jun; 46(12):2467-73. PubMed ID: 12773050
[TBL] [Abstract][Full Text] [Related]
34. Gallic acid inhibits the migration and invasion of A375.S2 human melanoma cells through the inhibition of matrix metalloproteinase-2 and Ras.
Lo C; Lai TY; Yang JS; Yang JH; Ma YS; Weng SW; Lin HY; Chen HY; Lin JG; Chung JG
Melanoma Res; 2011 Aug; 21(4):267-73. PubMed ID: 21734530
[TBL] [Abstract][Full Text] [Related]
35. Design and characterization of a new class of inhibitors of ras activation.
Colombo S; Peri F; Tisi R; Nicotra F; Martegani E
Ann N Y Acad Sci; 2004 Dec; 1030():52-61. PubMed ID: 15659780
[TBL] [Abstract][Full Text] [Related]
36. In silico carborane docking to proteins and potential drug targets.
Calvaresi M; Zerbetto F
J Chem Inf Model; 2011 Aug; 51(8):1882-96. PubMed ID: 21774557
[TBL] [Abstract][Full Text] [Related]
37. Structure-activity relationship of boronic acid derivatives of tyropeptin: proteasome inhibitors.
Watanabe T; Abe H; Momose I; Takahashi Y; Ikeda D; Akamatsu Y
Bioorg Med Chem Lett; 2010 Oct; 20(19):5839-42. PubMed ID: 20727746
[TBL] [Abstract][Full Text] [Related]
38. Small molecule inhibition of protein depalmitoylation as a new approach towards downregulation of oncogenic Ras signalling.
Dekker FJ; Hedberg C
Bioorg Med Chem; 2011 Feb; 19(4):1376-80. PubMed ID: 21129981
[TBL] [Abstract][Full Text] [Related]
39. Transmembrane signaling pathway mediates oxidized low-density lipoprotein-induced expression of plasminogen activator inhibitor-1 in vascular endothelial cells.
Sangle GV; Zhao R; Shen GX
Am J Physiol Endocrinol Metab; 2008 Nov; 295(5):E1243-54. PubMed ID: 18796547
[TBL] [Abstract][Full Text] [Related]
40. Cyclization of natural products.
O'Connor SE
Nat Chem Biol; 2006 Oct; 2(10):511-2. PubMed ID: 16983382
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
